← Leaderboards
Peter Kraft
Harvard School Of Public Health
$5,095,658
Attributed
$7,731,206
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2009–23$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$18,305,602 · 11
By mechanism
U19$11,759,785 · 2
R01$2,902,343 · 2
U01$2,398,897 · 3
R21$754,360 · 2
UH2$410,467 · 1
R03$79,750 · 1
Top collaborators
- Rulla M Tamimi7 shared
- Habibul Ahsan5 shared
- Joan Siefert Brugge5 shared
- Stephen J Chanock5 shared
- Jack Cuzick5 shared
- Douglas Frederick Easton5 shared
- Matthew L Freedman5 shared
- Judy Ellen Garber5 shared
Most similar at Harvard School Of Public Health
Same institution · by research overlap
- Douglas Frederick Easton$5,606,502
- Rudolf Kaaks$0
- Jack Cuzick$0
- Curtis Huttenhower$20,145,349
- Molin Wang$3,697,703
Others in their field
Top investigators on “Genome Wide Association Study”
- David Heimbrook · Leidos Biomedical Research, Inc.$111,485,565
- James D Crapo · University Of Colorado Denver$80,593,932
- David A Bennett · Rush University Medical Center$78,184,796
- Michael A Province · Washington University$77,809,700
- Li-San Wang · University Of Pennsylvania$67,433,768
- Gerard David Schellenberg · University Of California San Diego$65,975,701
Research focus
Genome Wide Association StudyRisk FactorsCohortGeneticCancer RiskVariantGenesMalignant Breast NeoplasmWomanBaseBreast Cancer Risk FactorMalignant NeoplasmsTranslationsResourcesBiologyFamily History OfGenome-WideGenetic VariantHigh RiskIncidenceBreastTumorProspectiveFuture
Grant awards (26)
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer$494,993
U01 · FY2023 · CA
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer$511,750
R01 · FY2022 · CA
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles$501,104
R01 · FY2022 · CA
Multifactoral breast cancer risk prediction accounting for ethnic and tumor diversity$325,356
U01 · FY2022 · CA · contact PI
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles$764,647
R01 · FY2021 · CA
Multifactoral breast cancer risk prediction accounting for ethnic and tumor diversity$637,691
U01 · FY2021 · CA · contact PI
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer$531,968
R01 · FY2021 · CA
Multifactoral breast cancer risk prediction accounting for ethnic and tumor diversity$683,035
U01 · FY2020 · CA · contact PI
Leveraging cross-cancer shared heritability to better understand the genetic architecture of cancer$592,874
R01 · FY2020 · CA
The Genetic Architecture of Breast Parenchymal Textural Features and its Implications for Breast Cancer Risk$79,750
R03 · FY2019 · CA · contact PI
Leveraging GxE interaction to understand pancreatic cancer and altered metabolism$180,033
UH2 · FY2016 · CA · contact PI
Leveraging GxE interaction to understand pancreatic cancer and altered metabolism$230,434
UH2 · FY2015 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$574,120
U19 · FY2014 · CA
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,309,806
U19 · FY2013 · CA
Epidemiologic Studies$281,094
U19 · FY2013 · CA · contact PI
Methods to Identify Genetic Markers That Interact with Multiple Environmental Exp$151,810
R21 · FY2013 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,486,910
U19 · FY2012 · CA
Epidemiologic Studies$311,174
U19 · FY2012 · CA · contact PI
Methods to Identify Genetic Markers That Interact with Multiple Environmental Exp$193,800
R21 · FY2012 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,465,094
U19 · FY2011 · CA
Epidemiologic Studies$292,480
U19 · FY2011 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,738,466
U19 · FY2010 · CA
Epidemiologic Studies$300,641
U19 · FY2010 · CA · contact PI
Sequencing regions assoc with breast cancer risk in European and African American$257,822
U01 · FY2010 · HG · contact PI
Evaluating the Clinical Validity of Novel Gene-Environment Risk Profiles$204,375
R21 · FY2010 · DK · contact PI
Evaluating the Clinical Validity of Novel Gene-Environment Risk Profiles$204,375
R21 · FY2009 · DK · contact PI